Multiomic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes


Brian Warnecke, Misako Nagasaka, Mohammed Najeeb Al Hallak, Sahar Bannoura, Andrew Elliott, Balazs Halmos, Dave Hoon, Sourat Darabi, Alex Farrell, Ammar Sukari, Milan Radovich, Emil Lou, George Sledge, Wafik El-Deiry, Asfar Azmi, Chul Kim


  • RCC1 expression is a negative prognostic marker in NSCLC, PC, and CRC
  • Further studies to investigate this at the molecular level may be a potential opportunity for novel targeted drug development
Download Publication